GHRS GH Research PLC
- Stocks
- Healthcare
- NASDAQ: GHRS
Price (delayed)
$13.03
Market cap
$808.23M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.74
Enterprise value
$555M
gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.
Highlights
The quick ratio has soared by 51% YoY
GH Research's debt has decreased by 15% YoY
GH Research's equity has surged by 53% YoY but it has decreased by 2.3% QoQ
GH Research's net income has decreased by 17% YoY but it has increased by 2.6% from the previous quarter
Key stats
What are the main financial stats of GHRS
Market
Valuations
Earnings
Shares outstanding
62.03M
Market cap
$808.23M
Enterprise value
$555M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.67
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$53M
Net income
-$41.02M
EBIT
-$40.31M
EBITDA
-$39.99M
Free cash flow
-$48.91M
Per share
Balance sheet
Liquidity
EPS
-$0.74
EPS diluted
-$0.74
Free cash flow per share
-$0.79
Book value per share
$4.89
Revenue per share
$0
TBVPS
$5.05
Total assets
$313.43M
Total liabilities
$10.25M
Debt
$647,000
Equity
$303.18M
Working capital
$283.91M
Debt to equity
0
Current ratio
29.49
Quick ratio
29.25
Net debt/EBITDA
6.33
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-16.1%
Return on equity
-16.7%
Return on invested capital
-54.4%
Return on capital employed
-13.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GHRS stock price
How has the GH Research stock price performed over time
Intraday
3.74%
1 week
7.69%
1 month
-20.98%
1 year
32.42%
YTD
86.14%
QTD
6.89%
Financial performance
How have GH Research's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$53M
Net income
-$41.02M
Gross margin
N/A
Net margin
N/A
GH Research's net income has decreased by 17% YoY but it has increased by 2.6% from the previous quarter
GH Research's operating income has decreased by 16% YoY and by 2.9% from the previous quarter
Price vs fundamentals
How does GHRS's price correlate with its fundamentals
Growth
What is GH Research's growth rate over time
Valuation
What is GH Research stock price valuation
P/E
N/A
P/B
2.67
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GHRS's EPS is down by 10% year-on-year but it is up by 6% since the previous quarter
GH Research's equity has surged by 53% YoY but it has decreased by 2.3% QoQ
The price to book (P/B) is 22% more than the last 4 quarters average of 2.1
Efficiency
How efficient is GH Research business performance
GHRS's return on invested capital has dropped by 110% year-on-year and by 18% since the previous quarter
The return on assets is up by 13% since the previous quarter
GHRS's return on equity is up by 13% since the previous quarter
Dividends
What is GHRS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GHRS.
Financial health
How did GH Research financials performed over time
The quick ratio has soared by 51% YoY
GH Research's total assets has soared by 51% YoY but it has decreased by 2.2% from the previous quarter
GH Research's debt is 100% lower than its equity
GH Research's equity has surged by 53% YoY but it has decreased by 2.3% QoQ
GH Research's debt has decreased by 15% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.